NT5E and neoplasm: Furthermore, extracellular vesicles from B cells through CD39 and CD73 vesicle-incorporated proteins hydrolyze eATP from chemotherapy-treated tumor cells into adenosine, thus impairing CD8+ T cell responses (131).